Skip to main content
News

Multiple Sclerosis and Hyperbaric Oxygen Therapy

Multiple Sclerosis and HBOT

March is MS awareness month. This complex, unpredictable, and often disabling disease attacks nerve cells of the brain and spinal cord, interrupting the flow of signals between the central nervous system and the rest of the body. At least 2.3 million people are estimated to live with MS, which can cause fatigue; impaired vision; problems with balance and walking; numbness, pain and other sensory changes; bladder and bowel dysfunction; cognition and memory issues; and more.
Although there is no cure for MS, a range of disease-modifying drug therapies have been developed to decrease MS disease activity and slow its rate of progression. There are also many therapies—pharmacological and otherwise—that can mitigate MS-related disability and treat symptoms
associated with the disease.
One of these is Hyperbaric Oxygen Therapy (HBOT), where a person breathes 100% medical-grade oxygen—a key building block of the body that plays a role in reducing inflammation and repairing damaged tissue—under increased pressure. Although there has not been rigorous study of HBOT’s efficacy in treating MS, there is medical literature dating back to the 1980s indicating its effectiveness in the treatment of some individuals with MS, particularly preserving their cerebellar function. While these studies have not been widely embraced in the U.S., they are taken seriously in other parts of the world, including the UK, where over 110 HBOT facilities treat MS patients. To learn more about how HBOT can work for you or a loved one with MS or other health challenges, visit hyperbaricsofsunvalley.com.

Join the discussion 351 Comments

Leave a Reply

Share